roject iocide onfidential nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 ---slide--- obacoat nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 3 he sole purpose of this memorandum is to provide information on ichem the ompany to those parties who have expressed an interest in the business carried on by the ompany in order to assist them in assessing whether they wish to make investigations of their own and enter into negotiations to invest in the ompany eloitte rivate eloitte is acting solely as financial adviser to the shareholder of the ompany the hareholder for the purposes of contacting potential investors for the sale of the ompany and will not regard any other person whether or not a recipient of this memorandum as its client in relation to that transaction his document is strictly private and confidential and is intended solely for the information of the addressee of the accompanying letter t is not an invitation for public subscription and should not be reproduced circulated or used for any purpose other than assisting with the assessment of the ompany by the persons to whom this memorandum is delivered his document is made available to you strictly on the basis of the confidentiality agreement that has already been signed and returned by you and constitutes onfidential nformation for the purposes of that agreement ccordingly this document and all onfidential nformation provided are returnable to eloitte in accordance with the terms of the confidentiality agreement ny person in possession of this memorandum should familiarise themselves with the terms of the confidentiality agreement before reading circulating or using this memorandum his memorandum is being issued by eloitte on behalf of the hareholder directors and interim directors of the ompany the irectors who have authorised its issue otice is given that 1 he information relating to the ompany contained herein has been provided by the ompany his information has not been independently verified by eloitte 2 nder no circumstances will the hareholder the ompany eloitte or any of their respective subsidiaries affiliates representatives partners directors interim directors officers employees advisers or agents collectively the elevant arties be responsible for any of the information in this memorandum including the forecasts and details of the market hese are supplied as a guide only and do not purport to contain all the information that an interested party may require y accepting this memorandum the recipient acknowledges that it will be solely responsible for making its own investigations including the costs and expenses incurred and forming its own view as to the condition and prospects of the ompany and the accuracy and completeness of the statements contained herein 3 his memorandum includes certain statements estimates and projections provided by the ompany with respect to its anticipated future performance uch statements estimates and projections reflect various assumptions concerning anticipated results and are subject to significant business economic and competitive uncertainties and contingencies many of which are or may be beyond the control of the ompany ccordingly there can be no assurance that such statements estimates and projections will be realised he actual results may vary from those projected and those variations may be material o representations are or will be made by any party as to the accuracy or completeness of such statements estimates and projections or that any projection will be achieved 4 one of the elevant arties has any authority to make or give any representation or warranty whatsoever in relation to the business or prospects of the ompany and makes no such representation or warranty 5 he information contained herein and any further information whether written electronic or oral relating to the ompany supplied by any of the elevant arties is and will be supplied on the condition that none of the elevant arties or any other person whatsoever is liable for any error omission or inaccuracy therein nor for any loss or damage sustained by an investor in the business placing reliance on such information including any error omission or inaccuracy resulting from any negligent act or omission of any of the elevant arties or any other person o party accepts any responsibility or gives any undertaking to provide further information including any information required to correct any earlier inaccuracy or error 6 he information contained herein does not and will not form any part of a contract urthermore it does not constitute an offer capable of acceptance and no binding commitment may be entered into on the basis of the information contained herein 7 either the receipt of this memorandum nor any information whether written electronic or oral made available in connection with the proposed investment in the ompany constitutes or is to be taken as constituting the giving of investment advice by any of the elevant arties 8 ny proposal to invest in the ompany made in due course must be in accordance with the procedure described separately in the letter from eloitte addressed to each recipient 9 o representations or warranties are given in or in respect of this memorandum or any further information supplied 10 eloitte will act as a primary point of contact for interested parties nless specifically agreed in writing by the hareholder or eloitte under no circumstances should potential interested parties contact the management or employees of the ompany or the hareholder or visit any sites used by the ompany 11 his memorandum should not be considered as a recommendation by any of the elevant arties to invest in the ompany and recipients interested in investing in the ompany are recommended to seek their own independent financial legal and other advice from persons authorised and specialising as necessary in investments of the kind in question ecipients should be aware that any investment activity may expose them to a risk of losing the property invested 12 ecipients of this memorandum in jurisdictions outside elgium should inform themselves about and observe all applicable legal requirements in their jurisdictions n particular the distribution of this memorandum in certain jurisdictions may be restricted by law and accordingly recipients represent that they are able to receive this memorandum without contravention of any unfulfilled registration requirements or other legal restrictions in the jurisdiction in which they reside or conduct business 13 his communication is directed only at persons who i have professional experience in matters relating to investments or ii inside the nited ingdom persons falling within rticle 49 2 a to d high net worth companies unincorporated associations etc of the inancial ervices and arkets ct 2000 inancial romotion rder 2001 all such persons together being referred to as relevant persons his communication must not be acted on or relied on by persons who are not relevant persons ny investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons 14 he securities of the ompany have not been and will not be registered under the nited tates ecurities ct of 1933 as amended the ecurities ct or with the securities regulatory authority of any jurisdiction and may not be offered or sold in the nited tates or to persons except pursuant to an exemption from such registration his memorandum is being distributed in the nited tates only to a limited number of accredited investors as defined in egulation under the ecurities ct isclaimer ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 4 xecutive summary 5 olution 10 usiness model 15 roduct development 17 o-to-market 19 uman resources 24 26 inancials 28 ase case 29 orst case 35 stimated financing needs 41 ransaction proposal 43 ontacts 45 ppendix 47 his memorandum contains 54 pages able of contents ---slide--- 5 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya xecutive summary ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 6 usiness overview xecutive summary ithcote urope hereinafter ithcote founded in 1966 in elgium was originally a subsidiary of ithcote orp oday the company is in the hands of hristophe eclercq hereinafter anagement the owner and ithcote is specialized in formulating manufacturing and applying anti- corrosion anti-adhesion and anti-wear coatings he company offers several metal treatment processes for the chemical industry food chains precision mechanics construction of household appliances maritime or road transport anagement recently invested substantially in their department and developed a virucidal bactericidal and fungicidal coating his new product is named obacoat hereinafter obacoat obacoat s effectiveness has already been approved and tested against ovid-19 by a laboratory from the niversity of iège ompany description imeline ithcote is partially split to externalize obacoat-related activities ithcote is bought by eclercq obacoat production is subcontracted test batch is produced for industry partners eginning of the research and development of obacoat 2008 2013 2018 2021 12 2021 reation of a uxemburg subsidiary the relay of ithcote with ermany and the rand uchy 2020 he results of the scientific laboratory study are successful reation of ithcote subsidiary of ithcote orp 1966 2022 anagement intends to raise 1 to close out 2022 ource anagement ichem obacoat has originally been developed by ithcote owever the new project will be carried by a new entity ichem hereinafter ichem in order to isolate the new project from the historical activities and thereby allowing new investors to support the new project without regard to ithcote s activities ichem is the product of the partial split of ithcote uring this operation three patent applications related to obacoat were transferred in the new entity n the future ichem will be the sole responsible entity for the manufacturing and commercialization of obacoat ew entity ichem ithcote atents ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 7 usiness overview xecutive summary egal form limited liability company ocation ourcelles ainaut elgium ate of foundation 30 12 2021 nterprise number 0779 619 682 - el codes 46751 20130 20590 70220 7112101 ull-time equivalent 1 actsheet n ebruary 2022 a capital increase of the new entity ichem was done by anagement for an amount of 467k anagement plans to 1 or 2 additional capital injections to support the development of the company he purpose of this fund raising is to finance the working capital needs generated by the rapid growth of the company and the company s investment plan anagement is open to two different types of transactions apital increase onvertible loan agreement roposed transaction ichem hristophe eclercq yscare hristel upriez ithcote urope 50 100 100 50 wnership ource anagement ichem ource anque arrefour des ntreprises anagement ichem undraising entity ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 8 anagement forecasts an increase in production volumes through the establishment of partnerships with large industrial players he construction of an own production facility is foreseen his will increase capacity from 37 tons to 607 tons ey financials xecutive summary ncreasing customer demand drives production volumes ource anagement ichem eloitte analysis 37 ons orecast 2022 607 ons orecast 2026 et cash flow evolution between 2022 and 2023 hase 1 hase 2 unding need hase n order to finance the working capital requirement generated by the rapid growth of the company and the investment plan ppendix anagement is willing to raise 1 000k hase n order to start the construction of its production facility anagement plans a second financing round estimated at 2 000k 1 000k 2 000k ource anagement ichem eloitte analysis uccessful capital increase of 467k by ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 9 ey investment factors xecutive summary trong product obacoat is a new developed product that has been technically validated by several academic studies and has won the 2020 ealth nnovation ward 02 01 artnership with large industry manufacturers anagement has partnerships with large industrial manufacturers across different industry segments such as randeco and aurecia 04 03 ositive environmental impact xceptional durability y its long durability compared to competing products and the non- usage of chemical biocides in the coating obacoat shows a strong positive environmental impact especially compared to its closest industry peers 05 xperience and qualifications he strong and high-quality members of the current team make ichem a company capable of achieving outstanding results in terms of production and commercialization of this promising product 06 ow price compared to competitors ow production costs enable anagement to set a competitive price compared to competitive products nnovative solution in a growing market n addition to being an innovative product responding to customers need the global antimicrobial coating market is forecasted to grow at a 10 5 ource anagement ichem ---slide--- 10 10 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya olution ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 11 olution to identified issues olution econtamination is constant and decontamination does not last ew technology can solve this problem he next innovation is self-sanitizing surfaces f we reduce and control the number of micro-organism by 99 9 we reduce our risk to less than 1 in a million of getting illnesses his is the next step in infection control 01 ovid-19 02 andemic era 03 uture pandemics 04 nti-microbial resistance ovid-19 will not be the world s last health emergency here is an urgent need for sustainable health emergency preparedness to deal with the next one ource 20 11 20 uman activity is leading us into a pandemic era e must reduce the risks to avoid an era of pandemics ource 29 10 20 uture pandemics will emerge more often spread faster do more damage to the global economy and kill more people than ovid 19 unless there is a major change in the way infectious diseases are tackled ource 16 11 20 he global phenomenon of anti-microbial resistance just as dangerous as a pandemic threatens to undo a century of medical progress ource 01 12 20 dentified issues olution ource anagement ichem ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 12 roduct description olution obacoat is a transparent disinfectant coating that has a mechanical no chemical effect on micro-organisms echnology he product consists of millions of small points which act on viruses bacteria or fungi y attracting them the micro-organisms explode like balloons his innovation consists of a strong chemical bond covalent bond between quats and hybrid polymer ceramic ermanent action ased on very solid functionalized hybrid ceramic it is very resistant and very durable ts effectiveness does not deteriorate over time this has been scientifically proven for at least 12 years ositive green impact y its action obacoat reduces the use of chemical biocides and helps to preserve the biodiversity and the planet obacoat o be approved as a disinfectant product its microbial elimination rate must reach 99 in less than 24 hours esearch realized by niversity of iège virology laboratory on obacoat shows an elimination rate of over 99 99 against the ovid-19 virus in less than one hour pproved by uropean regulation study shows that obacoat is very effective on different surfaces y analyzing the effectiveness of the product on different types of stainless steel and on glass results show an elimination rate of 100 in less than one hour he product is also applicable on several different surfaces while remaining entirely transparent ffective on different surfaces esistance he product shows substantial scratches and abrasion resistance reated surface recognition lthough it is transparent a chemical reaction during which the surface gets blue allows to find out whether the surface has been already treated with obacoat ther advantages uaternary ammonium operation principle on viruses ource anagement ichem obacoat is an antiviral antibacterial and antifungal coating durable and non-toxic oal o improve the quality of life and health of populations in the short and long term alue proposition ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 13 xamples of application olution argetable markets pplication area ustomer examples aterials - lass - extile - tainless steel ousing - allpapers - ackaging dhesives - aint ransport - utomotive - levators - ublic transport edical - edical devices - mbulances ource anagement ichem obacoat is a coating that has the consistency of an aqueous solution that can be applied on various surfaces in different sectors of activity aried applications ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 14 ntellectual property olution atent application atent application atent application atent title anoceramic hybrid transparent and biocidal coating for solid support and solid support comprising such a coating and process for its preparation rocess for obtaining a coating mproved biocidal coating atent description ounding patent of obacoat which covers the creation of a covalent bond between a resin and an active principle called quats his patent concerns the introduction of an additional polymer tri-dimensional structure allowing an increased resistance to abrasion and fire daptation of patent for application on glass ate of filing 21 05 2020 25 06 2021 24 11 2021 irst assessment 15 11 2021 ssessment conclusion patentable application lanned for 03 2022 lanned for 03 2022 olding entity ichem ichem ichem iling authority uropean atent ffice elgian ntellectual roperty ffice elgian ntellectual roperty ffice eographic coverage nternational nternational nternational ollowing patent applications were filed by anagement 1 granted patent and 2 patent applications in progress ource anagement ichem ---slide--- 15 15 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya usiness model ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 16 or the moment the production of the product is subcontracted ost of the the company s costs are related to research and development s of 2025 the company wishes to internalize the production by acquiring its own production tool in order to 1 ontrol the production process 2 void confidentiality risks 3 ave a production capacity superior to that of subcontractors usiness model canvas usiness model alue proposition ost structure ompany key activities are esearch and development ales and marketing s of 2025 manufacturing the product ey activities ichem s key partners are aw materials suppliers niversities trategic industry partners ey partners he company is developing partnerships with distributors obacoat will be distributed according 3 pricing models ndirect product distributed by a distribution partner standard pricing or m irect product distributed by ichem value based on costs icensing the product royalties perceived istribution he label and the brand guarantee of quality will allow to reach the large industrial companies and create added value urrent industrial partners ustomer relations ustomer segments have been identified and are varied among them ransport aterials ousing edical ustomer segments he company will generate revenue through the sale of coatings to the above-cited customers segments evenue streams ource anagement ichem 1 2 3 ---slide--- 17 17 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya roduct development ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 18 anagement set up a timeline for the industrialization of obacoat the process is split in 3 phases ndustrialization roadmap roduct development 2021 2022 2023 2024 2025 2026 hase 0 hase 1 hase 2 hase 3 hase explanation he entire production is subcontracted anagement focuses on the development of its partnerships nternalization phase of the production construction of the production facility cale-up phase roduction model ubcontracting ubcontracting ubcontracting ubcontracting nternalized nternalized uantity produced on - ase case est production batch to industry partners 37 249 340 458 607 inancing needs - quity uasi-equity k 1 500 2 000 ndustrialization roadmap ealized orecast ource anagement ichem eloitte analysis artial split of ithcote of which 467k has already been financed from shareholders and ---slide--- 19 19 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya o-to-market ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 20 he global paint and coating biocide market is forecasted to grow at a 4 1 over the 2020 until 2026 period ore specifically the uropean market is expected to grow at 3 5 over the same period hen broken down the global antimicrobial coating market is forecasted to grow at a faster pace than the global biocide market with a 10 5 from 2021 until 2026 egion 2019 2026 2020-2026 orth merica 57 3 76 2 4 2 urope 51 3 65 1 3 5 hina 44 2 60 2 4 7 apan 5 25 6 75 3 8 ndia 9 74 13 1 4 4 her regions 23 1 30 8 4 3 otal 190 8 252 4 1 mong the different and numerous biocide coatings on the market the determining attributes of the product are the following urability ttribute measuring the time a treated surface remains protected against the proliferation of viruses bacteria or fungi ffectiveness ttribute measuring the elimination rate of the product iocide toxicity ttribute defined by the composition of the product and the use of toxic components or not ost players in this market meet only 1 or 2 of these attributes obacoat meets all 3 attributes arket trends o-to-market lobal paint and coating biocide market size growth rate by region 2019-2026 nnovative solution in a growing market urability easured in time urrent market offering 13 6 6 4 11 3 3 9 lobal biocide and antimicrobial coating markets evolution 2021-2026 illion ource arkets and markets 2020-2021 iocide coatings market ntimicrobial coatings market ource alibre esearch 2020 ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 21 roducer rigin ame of the product ctive rincple urability rice iter m iter rice m ocivity ichem ithocide uats 12 years 150 00 60 00 2 50 o ordichem urope ordichem uats 2 days 335 00 3 35 es isinfekts isinfekts uats 4 weeks 580 00 es etterclean services etterclean uats 750 00 es urface echnologies uats 1 year 600 00 100 00 6 00 es nano are iquid uard iquid uard uats 1 year 560 00 80 00 7 00 es llied ioscience urface ise2 uats 3 months 480 00 es hoto ctive hotoactive ilver 1 year 460 00 es ero etal ero etal opper 70 00 es ource anagement ichem ased on the key attributes of comparable products obacoat places itself in a strong position compared to its closest competitors by being cheaper and more durable dentified competitors o-to-market rice igh ow urability ow igh ompetitors obacoat and its competitors ource anagement ichem obacoat obacoat ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 22 ompetitive advantages o-to-market ompetitive advantages o chemical effect on microbial but a mechanical effect healthier co-friendly no biocide chemicals end up in nature ossible extension of the product current development of air conditioning sanitization and water disinfectant ransparency the product does not change the appearance of the original substrate rice cheaper than the closest competitors by a 4x factor urability more than 12 years of efficiency ource anagement ichem ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 23 ndustry lass producers utomotive suppliers allpaper manufacturers utomotive seats manufacturers ustomers aint- obain itro aurecia randeco dient urrent partnership status lass producers plans to entrust obacoat with the development of a dedicated solution applicable to glass for the public transport vehicle private vehicle airplane or building glass markets the surfaces to be treated announced are of the order of several million m2 per year global automotive supplier aurecia is in an industrial scale-up phase to apply this coating to all internal components of vehicles co-development contract is signed elgian wallpaper manufacturer 2nd uropean supplier in final test to industrialize the application of the obacoat on their production distribution contract is signed ctive in textile and leather seats for automotive sector dient would like to integrate a coating application and crosslinking system into its production line allowing already treated fabric to be taken out of production anagement has been working with large industrial players on key partnerships he company currently targets 4 industry sectors glass producers automotive suppliers wallpaper manufacturers and automotive seats manufacturers co-development contract and a supply agreement have been signed with respectively aurecia and randeco which secures an annual quantity of 300 ons by 2026 dvanced discussions with large industrial players ustomers o-to-market ource anagement ichem ---slide--- 24 24 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya uman resources ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 25 arid uhib is the scientific person behind the formula created for obacoat e will oversee the research and development in the new structure rofessional experience 2009 2018 esearch associate at enter for ducation and esearch on acromolecules niversity of iège elgium 2008 2009 scientific researcher at olymer hemistry aboratory orbonne niversity rance ducation 2005 2008 in olymer chemistry at niversity of au rance topic ynthesis and characterization of polythiophene derivatives for organic solar cells 2003 2004 aster in olymer sciences at niversity of aris- st- al- de- arne rance 1997 2003 aster in hemistry at niversity of renoble rance xperienced team uman resources eclercq bought ithcote in 2008 with the vision of becoming a pioneer in the research and development of coatings for the industry e is the of ichem rofessional experience 2008 oday anaging director at ithcote 2004 2008 irector and o-founder at ecube financial holding focused on the industrial sector 2004 2008 anaging director ociété ndustrielle ays 2002 2004 epartment responsible abricom uez 2000 2002 eputy operation director ersatel 1991 2000 istrict manager elgacom hristophe eclercq arid uhib ource anagement ichem oris aes joined ichem during 2022 and will be the company s new chief commercial officer in charge of defining obacoat s commercial strategy rofessional experience 2010 oday elf-employed anagement consultant arious assignments at ele rain eyware echnologies uller ailey antalus - ast killbuilders and euven 2001 2008 ommercial director alta ndustries ducation 2001 2003 in international eneral anagement at lerick euven ent elgium 1987 1991 aster in ndustrial ngineering at igh chool stend elgium oris aes ---slide--- 26 26 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 27 obacoat eaknesses hreats pportunities ew technology in a growing market nnovation capacity and technical resources nti-viral anti-fungal and anti-bacteria product igh-quality and performing ormula can be adapted to several application substrates reat networking due to activities of the firm in industrial textile igh potential and growing market ew technology and weak direct competitors eveloping a network of licensed applicators of the product rowing attention from the press isibility on the market through pro-bono development bola frica ependent on suppliers rand image still to be developed ependence on its anagement bility to apply the product may compete with licensed applicators uropean and international regulation trengths ource anagement ichem ---slide--- 28 28 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya inancials ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 29 inancials ase case ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 30 udget udget udget udget udget k 2022 2023 2024 2025 2026 urnover growth - 1035 44 38 32 urnover 2 756 31 293 44 999 61 962 81 622 urchases of goods and subcontracting -612 -4 256 -6 041 -8 487 -11 705 urchases of goods and subcontracting in of turnover -22 -14 -13 -14 -14 ross margin 2 145 27 037 38 958 53 476 69 918 ross margin in of turnover 78 86 87 86 86 -1 430 -10 011 -14 272 -19 714 -25 959 in of turnover -52 -32 -32 -32 -32 ayroll costs -87 -1 581 -2 088 -2 820 -3 627 ayroll costs in of turnover -3 -5 -5 -5 -4 ther operating expenses -5 -56 -56 -57 -57 623 15 389 22 542 30 886 40 275 in of turnover 23 49 50 50 49 epreciation and amortization -72 -491 -531 -525 -549 550 14 898 22 011 30 361 39 726 in of turnover 20 48 49 49 49 inancial result -2 -104 -96 -88 -80 rofit before tax 549 14 794 21 914 30 273 39 647 orporate income tax -137 -3 699 -5 479 -7 568 -9 912 et result 412 11 096 16 436 22 705 29 735 et result in of turnover 15 35 37 37 36 ase case orecasted inancials ource anagement ichem eloitte nalysis eneral remark inancials have been prepared based upon the budget estimated by anagement overview urnover ncreasing revenues are explained by the signing of several manufacturing contracts urchases of goods and subcontracting he bill of material exercise was used to determine this category of costs ariations of purchases of goods and subcontracting as a percentage of turnover are explained by the product mix osts linked to services and other goods were based upon anagement s experience ayroll costs ncreasing payroll costs are justified by the increase in he average margin over the studied period stands at 40 and is mainly explained by the low cost of materials purchased ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 31 ase case orecasted etailed 1 2 inancials urnover overview urnover split is derived from anagement s signed agreements and current discussions with industrial partners ross margin overview ill of aterial exercise allow anagement to foresee an average gross margin of 85 over the studied period udget udget udget udget udget k 2022 2023 2024 2025 2026 urnover growth - 1035 44 38 32 urnover - randeco 2 756 14 606 14 621 14 584 14 547 urnover - aurecia - 2 779 12 184 23 149 36 286 urnover - aint- obain - 13 908 18 194 23 458 29 322 urnover - dient - - - 772 1 466 urnover 2 756 31 293 44 999 61 962 81 622 aw materials - randeco -492 -2 882 -3 189 -3 516 -3 876 aw materials - aurecia - -274 -1 329 -2 790 -4 834 aw materials - aint- obain - -290 -420 -598 -826 aw materials - dient - - - -93 -195 upplies purchases -46 -311 -425 -573 -759 ub-contracting -74 -498 -679 -917 -1 214 urchases of goods and subcontracting -612 -4 256 -6 041 -8 487 -11 705 urchases of goods and subcontracting in of turnover -22 -14 -13 -14 -14 ross margin 2 145 27 037 38 958 53 476 69 918 ross margin in of turnover 78 86 87 86 86 ource anagement ichem eloitte nalysis orecasted production volumes ons ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 32 ase case orecasted etailed 2 2 inancials overview dvertising and communication budget ncreasing expenses in marketing are explained by the need to rapidly build product notoriety esearch and development expenses are needed to support the product and decline the original recipe to different sector applications istribution his cost category relates to the existing distribution contract with randeco ayroll costs overview ncreasing payroll costs are explained by the increasing number of necessary to deal with key accounts and assume in-house production evolution between 2022 and 2026 number of udget udget udget udget udget k 2022 2023 2024 2025 2026 ross margin 2 145 27 037 38 958 53 476 69 918 ross margin in of turnover 78 86 87 86 86 nsurance charges -16 -76 -158 -299 -470 elephone internet -8 -9 -10 -12 -15 ther subscriptions -30 -30 -50 -50 -50 uel transport -12 -15 -20 -25 -30 ompany vehicles -72 -288 -360 -468 -576 ravel and accommodation expenses -30 -60 -70 -85 -90 ater electricity and gas -24 -24 -30 -40 -45 aintenance and repair -30 -40 -50 -60 -70 omputer equipment -30 -35 -40 -45 -50 ub-contracting -20 -25 -30 -35 -40 acility cleaning -12 -15 -18 -21 -25 dvertising and communication budget -50 -240 -495 -950 -1 450 ent and rental charges -48 - - - - hartered accountants lawyers -12 -15 -20 -25 -30 esearch and development -144 -3 912 -5 625 -7 745 -10 203 atents -35 -35 -35 -35 -35 ommercial authorizations -10 -10 -10 -10 -10 istribution -413 -4 694 -6 750 -9 294 -12 243 anagement and third parties -434 -489 -502 -514 -527 -1 430 -10 011 -14 272 -19 714 -25 959 in of turnover -52 -32 -32 -32 -32 emuneration - anager -87 -89 -91 -94 -96 emuneration - mployee - -125 -128 -196 -201 emuneration - ales - -1 069 -1 460 -2 058 -2 685 emuneration - lue collars - -299 -409 -472 -644 ayroll costs -87 -1 581 -2 088 -2 820 -3 627 ayroll costs in of turnover -3 -5 -5 -5 -4 ther operating expenses -5 -56 -56 -57 -57 623 15 389 22 542 30 886 40 275 in of turnover 23 49 50 50 49 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 33 s ealized udget udget udget udget udget ays 2021 2022 2023 2024 2025 2026 - 51 43 46 53 58 - 424 167 160 160 130 - 29 26 24 24 23 - 446 184 183 189 165 ase case orecasted balance sheet inancials alance sheet overview ntangible assets atents are activated in the balance sheet and depreciated angible assets he company builds its production facility in 2023 orking capital requirement ncreasing sales volumes drive the working capital requirement ash and equivalent anagement assumed 0 payout ratio during the first 3 phases for the purpose of this exercise leading to increasing cash position over the years inancial debts nvestments in a factory construction study and associated architect fees 2022 are financed at 70 by bank funding he construction of the production facility 2023 is financed at 75 by bank funding orking capital evolution between 2022 and 2026 k alance sheet ealized udget udget udget udget udget k 2021 2022 2023 2024 2025 2026 ntangible assets - 399 290 181 116 67 angible assets 7 270 5 431 5 409 5 349 5 250 nventory - 710 1 944 2 655 3 710 4 181 rade receivables - 465 4 038 6 036 9 406 13 348 ther receivables - - - - 382 2 073 5 292 ash and equivalent 5 -532 5 659 19 177 36 211 58 860 otal assets 12 1 313 17 363 33 841 56 865 86 998 quity 3 881 11 977 28 413 51 118 80 853 apital 2 469 469 469 469 469 eserves result carried forward 0 412 11 508 27 944 50 649 80 384 otal financial debts - 188 4 029 3 706 3 375 3 035 ebt - 2022 - 188 174 159 145 129 ebt - 2023 - - 3 856 3 547 3 230 2 906 hort term debts 9 243 1 356 1 721 2 372 3 110 rade payables - 192 1 175 1 547 2 132 2 808 iscal debts - 44 50 - - -0 alary and social debts 9 7 132 174 239 302 otal liabilities 12 1 313 17 363 33 841 56 865 86 998 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 34 ase case ash flow generation inancials ash flow generation hase 1 he estimated financing need during phase 1 is estimated at 1 000k hase 2 urther investment in the production facility will lead to an additional financing need estimated at 2 000k hase 3 hase 1 hase 2 hase 1 hase 2 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 35 inancials orst case ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 36 udget udget udget udget udget k 2022 2023 2024 2025 2026 urnover growth - 197 28 36 31 urnover 2 747 8 165 10 478 14 237 18 693 urchases of goods and subcontracting -609 -1 187 -1 591 -2 238 -3 159 urchases of goods and subcontracting in of turnover -22 -15 -15 -16 -17 ross margin 2 137 6 979 8 887 11 998 15 534 ross margin in of turnover 78 85 85 84 83 -1 429 -3 281 -4 581 -6 314 -8 293 in of turnover -52 -40 -44 -44 -44 ayroll costs -87 -809 -880 -1 236 -1 494 ayroll costs in of turnover -3 -10 -8 -9 -8 ther operating expenses -5 -56 -56 -57 -57 617 2 834 3 370 4 391 5 689 in of turnover 22 35 32 31 30 epreciation and amortization -72 -491 -531 -525 -549 544 2 343 2 839 3 867 5 141 in of turnover 20 29 27 27 28 inancial result -2 -97 -90 -82 -75 rofit before tax 543 2 246 2 749 3 784 5 066 orporate income tax -136 -561 -687 -946 -1 267 et result 407 1 684 2 062 2 838 3 800 et result in of turnover 15 21 20 20 20 orst case orecasted inancials overview urnover ase case target production quantity is reduced from 607 to 164 in 2026 hus revenues increase at a slower rate than in the base case urchases of goods and subcontracting he bill of material exercise was used to determine this category of costs osts linked to services and other goods were estimated by anagement s experience ayroll costs eviewed production target induce a smaller increase in in he average margin over the studied period stands at 30 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 37 orst case orecasted etailed 1 2 inancials urnover overview urnover split is derived from a worst-case scenario estimated by anagement ross margin overview aintaining low costs of raw materials allows anagement to foresee an average gross margin of 83 over the studied period udget udget udget udget udget k 2022 2023 2024 2025 2026 urnover growth - 197 28 36 31 urnover - randeco 2 747 4 275 5 036 5 942 7 037 urnover - aurecia - 470 893 1 698 3 225 urnover - aint- obain - 3 420 4 549 6 173 7 624 urnover - dient - - - 424 806 urnover 2 747 8 165 10 478 14 237 18 693 aw materials - randeco -490 -844 -1 098 -1 432 -1 875 aw materials - aurecia - -46 -97 -205 -430 aw materials - aint- obain - -71 -105 -157 -215 aw materials - dient - - - -51 -107 upplies purchases -46 -87 -112 -151 -205 ub-contracting -73 -139 -179 -242 -328 urchases of goods and subcontracting -609 -1 187 -1 591 -2 238 -3 159 urchases of goods and subcontracting in of turnover -22 -15 -15 -16 -17 ross margin 2 137 6 979 8 887 11 998 15 534 ross margin in of turnover 78 85 85 84 83 ource anagement ichem eloitte nalysis orecasted production volumes ons ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 38 orst case orecasted etailed 2 2 inancials overview dvertising and communication budget ncreasing expenses in marketing are explained by the need to rapidly build product notoriety esearch and development expenses are needed to support the product and decline the original recipe to different sector applications istribution his cost category relates to the existing distribution contract with randeco ayroll costs overview increase at a slower rate than in the base case due to a reviewed target production quantity evolution between 2022 and 2026 number of udget udget udget udget udget k 2022 2023 2024 2025 2026 ross margin 2 137 6 979 8 887 11 998 15 534 ross margin in of turnover 78 85 85 84 83 nsurance charges -16 -76 -158 -299 -470 elephone internet -8 -9 -10 -12 -15 ther subscriptions -30 -30 -50 -50 -50 uel transport -12 -15 -20 -25 -30 ompany vehicles -72 -162 -162 -194 -216 ravel and accommodation expenses -30 -60 -70 -85 -90 ater electricity and gas -24 -24 -30 -40 -45 aintenance and repair -30 -40 -50 -60 -70 omputer equipment -30 -35 -40 -45 -50 ub-contracting -20 -25 -30 -35 -40 acility cleaning -12 -15 -18 -21 -25 dvertising and communication budget -50 -240 -495 -950 -1 450 ent and rental charges -48 - - - - hartered accountants lawyers -12 -15 -20 -25 -30 esearch and development -144 -776 -1 310 -1 780 -2 337 atents -35 -35 -35 -35 -35 ommercial authorizations -10 -10 -10 -10 -10 istribution -412 -1 225 -1 572 -2 136 -2 804 anagement and third parties -434 -489 -502 -514 -527 -1 429 -3 281 -4 581 -6 314 -8 293 in of turnover -52 -40 -44 -44 -44 emuneration - anager -87 -89 -91 -94 -96 emuneration - mployee - -125 -128 -196 -201 emuneration - ales - -445 -456 -631 -767 emuneration - lue collars - -150 -204 -314 -430 ayroll costs -87 -809 -880 -1 236 -1 494 ayroll costs in of turnover -3 -10 -8 -9 -8 ther operating expenses -5 -56 -56 -57 -57 617 2 834 3 370 4 391 5 689 in of turnover 22 35 32 31 30 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 39 s ealized udget udget udget udget udget ays 2021 2022 2023 2024 2025 2026 - 50 57 59 63 66 - 232 154 161 162 130 - 29 25 25 25 24 - 253 186 195 200 172 orst case orecasted balance sheet inancials alance sheet overview ntangible assets atents are activated in the balance sheet and depreciated angible assets he company builds its production facility in 2023 orking capital requirement ncreasing sales volumes drive the working capital requirement ash and equivalent anagement assumed 0 payout ratio during the first 3 phases for the purpose of this exercise leading to increasing cash position over the years inancial debts nvestments in a factory construction study and associated architect fees 2022 and the construction of the production facility 2023 are financed at 70 by bank funding orking capital evolution between 2022 and 2026 k alance sheet ealized udget udget udget udget udget k 2021 2022 2023 2024 2025 2026 ntangible assets - 399 290 181 116 67 angible assets 7 270 5 431 5 409 5 349 5 250 nventory - 388 502 700 994 1 129 rade receivables - 454 1 404 1 868 2 673 3 623 ther receivables - - - - - 191 602 ash and equivalent 5 -206 -863 496 2 083 4 437 otal assets 12 1 304 6 764 8 655 11 407 15 108 quity 3 877 2 561 4 623 7 461 11 261 apital 2 469 469 469 469 469 eserves result carried forward 0 408 2 092 4 154 6 992 10 792 otal financial debts - 188 3 772 3 470 3 160 2 842 ebt - 2022 - 188 174 159 145 129 ebt - 2023 - - 3 599 3 310 3 015 2 712 hort term debts 9 240 430 562 786 1 006 rade payables - 190 352 488 673 881 iscal debts - 43 11 0 - - alary and social debts 9 7 67 73 113 125 otal liabilities 12 1 304 6 764 8 655 11 407 15 108 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 40 orst case ash flow generation inancials ash flow generation hase 1 he estimated financing need during phase 1 is 1 000k hase 2 urther investment in the production facility will lead to an additional financing need estimated at 2 000k hase 1 hase 2 hase 3 hase 1 hase 2 ource anagement ichem eloitte nalysis ---slide--- 41 41 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya stimated financing needs ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 42 inancing needs and use of funding stimated financing needs unding need he financing requirement in either scenario is estimated at 1 000k buffer included in order to close out 2022 ase case se of funding k orst case se of funding k inancing assumptions ank funding 70 of investments in a factory construction study and associated architect fees foreseen in 2022 hareholders and capital raise 467k at the beginning of 2022 pre-money valuation of 4 203k undraising amount 1 000k ource anagement ichem eloitte nalysis ---slide--- 43 43 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya ransaction proposal ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 44 ey transaction parameters ransaction proposal ssuer ransaction structure ransaction size icket nvestors se of proceeds iming nformation ichem apital increase of ichem or convertible loan agreement inancing of the working capital requirements and the investment plan une 2022 for the closing fter signing of nformation emorandum fter acceptance of a non-binding offer hartered accountant report on the partial split patent applications bill of material and commercial agreements 1 000k inimum 500k ew shareholders institutional investors strategic or industrial investors ource anagement ichem overnance oard seat to be discussed ---slide--- 45 45 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya ontacts ---slide--- 46 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya lliot uzziconi unior onsultant ellruzziconi deloitte com 0498 78 53 18 édric agarrigue anager clagarrigue deloitte com 0497 79 43 38 rançois choenen enior onsultant fschoenen deloitte com 0491 52 98 06 incent revisan artner vtrevisan deloitte com 0475 56 00 35 eloitte rivate ontacts ---slide--- 47 47 2022 eloitte rivate onfidential roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya ppendix ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 48 ppendix pplication on several substrats ppendix xisting aint - oncrete ood - ource anagement ichem ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 49 ppendix ccelerated abrasion test on plasterboard samples ppendix ource anagement ichem obacoat 1000 cycles ther paint 200 cycles crylic paint 100 cycles ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 50 ppendix ashability and waterproofing ppendix ource anagement ichem ot treated all aper reated all aper with obacoat ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 51 ppendix ow to know if a surface is treated ppendix ource anagement ichem romothymol blue test romothymol blue test allows to check if a surface has been treated with obacoat ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 52 ppendix nvestment plan ppendix udget udget udget udget udget k 2022 2023 2024 2025 2026 actory construction study 25 - - - - rchitect fees factory construction 250 - - - - actory equipment - 1 500 - - - uilding - 4 043 - - - arketing study orth merica 20 - - - - arketing study sia 20 - - - - atent 1 70 - - - - atent 2 70 - - - - atent 3 70 - - - - ntellectual roperty 1 70 - - - - ntellectual roperty 2 70 - - - - ntellectual roperty 3 70 - - - - actory equipment - recurring and production increase - - 400 - - actory equipment - recurring and production increase - - - 400 - actory equipment - recurring and production increase - - - - 400 otal 735 5 543 400 400 400 ource anagement ichem eloitte nalysis ---slide--- roject iocide nformation emorandum issued to hibaud e éguillon and lexandre raconnier ndustrya 2022 eloitte rivate onfidential 53 1 2 3 4 5 6 7 8 9 efinition asic principles observed echnology application concept formulated nalytical and experimental critical function and or chracteristic proof of concept omponent validation in lab environment omponent validation in relevant environment ystem subsystem model or prototype demonstration in relevant environment ystem prototype demonstration ctual system completed through test and demonstration ctual system proven through succesful application ustomers ppendix echnology readiness level applied to obacoat customers ppendix ource anagement ichem eloitte nalysis ---slide--- he content and the layout of this presentation are the exclusive property of eloitte ccountancy hereafter eloitte and or its employees and are protected by copyright and other relevant intellectual property right laws and conventions bsolutely no reproduction in any form or via any medium is allowed without eloitte s express permission his presentation was drawn up in general terms and therefore cannot be depended on for specific situations lthough eloitte verifies the reliability of the information given such information is general and eloitte may under no circumstances be held liable for possible errors that might occur as a result of the use or the interpretation of this information without the assistance of eloitte he information that is contained in this presentation is based on the law regulations case-law specific cases rulings and other sources that exist at the time of the presentation onsequently subsequent changes in or to the foregoing about which eloitte bears no responsibility to inform the reader user can invalidate the information contained in the presentation pplication of the principles contained in the presentation will depend on the specific applicable circumstances and we advise you to request professional advice before taking or refraining from any action on the basis of the content of this presentation eloitte would be happy to assist the reader user by advising him on how to apply these principles in specific situations eloitte accepts no duty of due care or liability for any loss caused to a person who takes or refrains from any action as a result of any information contained in this presentation bout eloitte eloitte refers to one or more of eloitte ouche ohmatsu imited its global network of member firms and their related entities collectively the eloitte organisation also referred to as eloitte lobal and each of its member firms and related entities are legally separate and independent entities which cannot obligate or bind each other in respect of third parties and each member firm and related entity is liable only for its own acts and omissions and not those of each other does not provide services to clients lease see www deloitte com about to learn more eloitte rivate is the brand under which firms in the eloitte network provide services to privately owned entities and high-net-worth individuals eloitte is a leading global provider of audit and assurance consulting financial advisory risk advisory tax and related services ur global network of member firms and related entities in more than 150 countries and territories collectively the eloitte organisation serves four out of five ortune lobal 500 companies earn how eloitte s approximately 330 000 people make an impact that matters at www deloitte com 2022 or information contact eloitte rivate ccountancy dvisory ---slide---